Irish national real-world analysis of the clinical and economic impact of 21-gene oncotype DX® testing in early-stage, 1-3 lymph node-positive, oestrogen receptor-positive, HER2-negative, breast cancer
爱尔兰国家真实世界分析：21基因Oncotype DX®检测在早期、1-3个淋巴结阳性、雌激素受体阳性、HER2阴性乳腺癌中的临床和经济影响
期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-024-07486-5
Browne, I M; McLaughlin, R A; Weadick, C S; O'Sullivan, S; McSorley, L M; Hadi, D K; Millen, S J; Higgins, M J; Crown, J P; Prichard, R S; McCartan, D P; Hill, A Dk; Connolly, R M; Noonan, S A; O'Mahony, D; Murray, C; O'Hanlon-Brown, C; Hennessy, B T; Quinn, C M; Kelly, C M; O'Reilly, S; Morris, P G; Walshe, J M
